|Bid||39.04 x 1300|
|Ask||39.22 x 1100|
|Day's Range||38.10 - 39.63|
|52 Week Range||30.50 - 50.78|
|Beta (5Y Monthly)||1.06|
|PE Ratio (TTM)||24.67|
|Forward Dividend & Yield||0.96 (2.43%)|
|Ex-Dividend Date||May 12, 2019|
|1y Target Est||48.85|
President Trump ordered General Motors to make ventilators late Friday, invoking the Cold War-era Defense Production Act.
The governor pushes back against President Trump’s assertion that the state won’t need at least 30,000 of the machines in COVID-19 battle.
Koninklijke Philips N.V. (“Royal Philips”) (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its issue of EUR 500 million fixed rate notes due 2025 and EUR 500 million fixed rate notes due 2030 (together the “Notes”). The net proceeds of the offering are intended for general company purposes and sustainable innovation expenditures as defined in the ESG framework available on the debt section of Philips Investor Relations website, and will further enhance the company’s liquidity position in view of the possible continued impact of the COVID-19 pandemic on financial markets in 2020. The issue price for the notes due 2025 is 99.550% with a Coupon of 1.375%, resulting in a yield of 1.469%.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Royal Philips N.V. Frankfurt am Main, March 25, 2020 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Royal Philips N.V. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Children’s Hospital of Georgia has adopted Philips’ automated early detection and warning solution (IntelliVue GuardianSoftware) for pediatrics. This scalable solution, which could be comprised of a combination of patient monitoring, telehealth, predictive analytics software and services, enables quick identification of signals of clinical patient deterioration and triggers a warning notification to the hospital staff allowing faster response times.
Broad powers over U.S. factories brought in by President Donald Trump could fuel protectionism and jeopardise the supply of critical medical equipment to fight the coronavirus pandemic, Dutch health technology company Philips warned on Tuesday. Trump said on Friday he had put into action the U.S. Defense Production Act, a law dating back to the Korean War of the 1950s that grants him sweeping authority to expedite and expand the supply of resources from U.S. factories. "We are worried", Philips <PHG.AS> spokesman Steve Klink told Reuters on Tuesday, referring to the act.
Royal Philips (NYSE: PHG, AEX: PHIA) today provides an update on its EUR 1.5 billion share buyback program for capital reduction purposes, that was announced on January 29, 2019. As of today, 50.3% of the program has been completed through repurchases by an intermediary to allow for purchases in the open market during both open and closed periods. The remainder of the program will be executed through one or more individual forward transactions, to be entered into in the course of 2020, with expected settlement dates in the second half of 2021.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is increasing the production of certain critical care products and solutions to help diagnose and treat patients with the new coronavirus disease (COVID-19). Other Philips products and solutions to help address the preparedness, response and recovery needs of COVID-19 include a range of diagnostic imaging systems (CT, mobile diagnostic X-ray, and ultrasound) to help diagnose and assess respiratory conditions, as well as hospital telehealth solutions to centrally monitor and manage patients in the intensive care unit (Philips eICU program), and telehealth solutions to connect caregivers and patients at home. For example, Philips is ramping up the production of hospital ventilators and plans to double production within the next eight weeks and achieve a four-fold increase by the third quarter of 2020.
March 18, 2020 Amsterdam, the Netherlands – Frans van Houten, CEO of Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today provided an.
March 16, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today convenes the 2020 Annual General Meeting of Shareholders (AGM) and publishes the.
To the annoyance of some shareholders, Koninklijke Philips (AMS:PHIA) shares are down a considerable 31% in the last...
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
March 12, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the company was named the first.
Royal Philips (NYSE: PHG, AEX: PHIA), a leading health technology company, and Jackson Health System, one of the nation’s largest public health systems, today announced new findings from a performance improvement evaluation at Jackson Memorial Hospital. Nursing staff gave the new model a 90%* satisfaction rating, up from 8%* prior to the new system  – an 82% improvement.
Today we're going to take a look at the well-established Koninklijke Philips N.V. (AMS:PHIA). The company's stock saw...
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the HealthSuite System of Engagement, an integrated, modular set of standards-based capabilities that support the development of digital health propositions, including new capabilities for cloud-based managed AI workflow and DICOM interoperability. “While there are compelling examples of digitalization improving healthcare delivery, too often patients and care providers struggle within a complex, fragmented technology and data landscape that hampers the deployment of innovative healthcare services,” said Jeroen Tas, Chief Innovation & Strategy Officer, member of the Executive Committee Royal Philips.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2020 report: ‘The age of opportunity: Empowering the next generation to transform healthcare.’ The 2020 report is the first large-scale survey of this younger generation of healthcare professionals, capturing feedback from nearly 3,000 respondents across 15 countries who provide unique perspectives into how prepared they are to manage tomorrow’s healthcare. Now in its fifth year, the Future Health Index 2020 report reveals critical insights from this new generation of healthcare professionals under the age of 40, a group that will comprise most of the healthcare workforce over the next 20 years.
Moody's Investors Service, ("Moody's") assigned a long-term issuer rating of Baa3 to Signify N.V. (Signify). Signify's Baa3 rating balances its leading market positions in conventional and LED lighting business across the value-chain, its strong brand recognition, the group's diversification across different geographies as well as its proven track-record to transform the business from conventional lighting to LED with its current weak profitability compared to other rated manufacturing peers, its limited ability to organically grow its topline due to the downscaling of its very profitable conventional lighting business and a temporarily elevated leverage of approximately 3.8x, following the acquisition of Cooper Lighting Solutions. Cooper's activities are focused on professional lighting, lighting controls, and connected lighting.
March 3, 2020 Now with FDA 510(K) clearance, web-based dashboard supports real-time data transfer to empower clinical decision-making in emergency careEnhanced.
March 2, 2020 Global survey reveals 36% have slept separately from their bed partner in an attempt to improve sleep74% admit to using cell phones in bed60% agree they are.
Amsterdam, the Netherlands & Osnabrück, Germany – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Paracelsus Clinics, today announced they have entered into a strategic partnership for the next eight years. The partnership is focused on continuous modernization of Paracelsus Clinics’ medical imaging systems.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the European Society of Radiology (ESR), today announced a collaboration to host an Ultrasound Academy at the European Congress of Radiology, ECR 2020 (Vienna, Austria, 11-15 March). Taking place on 12 March, the educational program will be led by experts in the field, with classes dedicated to clinical education in four fields of ultrasound: vascular, musculoskeletal, interventional radiology and liver shear wave elastography.
Philips is set to meet all the targets proposed in its 5-year ‘Healthy people, Sustainable planet’ program, with expansion of its renewable energy sourcing initiatives, and Green Revenues  accounting for 67% of revenues and Circular Products & Solutions  accounting for 13% of revenues in 2019. Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is another step closer to becoming carbon-neutral in its own operations in 2020, with its US and Dutch facilities now 100%-powered by renewable electricity. This action on CO2 emissions reduction contributed to a fall in Philips’ operational carbon footprint of 10% compared to 2018, even as the company recorded 4.5% comparable sales growth.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2019, and expects to file the report on Form 20-F with the US Securities and Exchange Commission later today (www.sec.gov). Philips’ Annual Report 2019 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on April 30, 2020. The Annual Report 2019 is available to shareholders and other interested parties via this link.
February 24, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has again been recognized as a Derwent Top 100.